Literature DB >> 29363354

Clinical Toxicology of Yew Poisoning.

Alexander W Labossiere1, Dennis F Thompson1.   

Abstract

OBJECTIVES: Yew plant materials contain highly toxic taxine alkaloids. Serious ingestions can result in life-threatening toxicity. The purpose of this article is to summarize the literature on the treatment of acute yew poisoning. DATA SOURCES: PubMed (January 1946 to November 2017) was searched using the search terms "taxus/po". EMBASE (1980 to November 2017) was searched using the search terms "taxus/to" and "yew.mp." Web of Science (1945 to November 2017) was searched using the text words taxus, taxine, and yew. STUDY SELECTION AND DATA EXTRACTION: Available English language articles involving case reports, epidemiology, treatment, and outcomes were included. DATA SYNTHESIS: Although not uncommon, unintentional yew poisoning rarely results in significant morbidity or mortality. A total of 26 case reports of yew poisoning were evaluated along with 4 case series articles (totaling 22 additional cases). Only 4 of the 48 total cases (8%) were accidental poisonings, the rest being deliberate ingestions. In 20 patients (42%), it resulted in fatalities. Severe, acute yew poisoning results in symptomatology largely resistant to pharmacotherapy intervention.
CONCLUSIONS: Most nonintentional ingestions of yew plant constituents are asymptomatic and require little intervention. Severe poisoning can result in life-threatening cardiac toxicity and require aggressive supportive care. Therapeutic interventions, such as sodium bicarbonate, digoxin immune fab, and hemodialysis that have been utilized in case studies and case series in the literature have little proven benefit. Extracorporeal life support should be considered in severe yew poisoning.

Entities:  

Keywords:  clinical toxicology; emergency medicine; poison control; supportive care; taxines; yew

Mesh:

Year:  2018        PMID: 29363354     DOI: 10.1177/1060028017754225

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

1.  Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019.

Authors:  Shaokui Wei; Manette T Niu; Graça M Dores
Journal:  Drugs Real World Outcomes       Date:  2021-03-15

2.  [Cardiogenic shock following yew needle poisoning : Digoxin immune fab, va-ECMO and albumin dialysis for the treatment of a suicidal yew leaf poisoning].

Authors:  Jonas Ajouri; R M Muellenbach; C B Rolfes; K Weber; F Schuppert; A A Peivandi; C Reyher
Journal:  Anaesthesist       Date:  2021-10-04       Impact factor: 1.041

3.  Pica (Allotriophagy): An Underestimated Risk Factor for Severe Leptospirosis (Weil's Diseases)? Report of a Leptospira Septic Shock Successfully Managed with ECMO.

Authors:  Adam Fabiani; Eugenia Dal Bo; Stefano Di Bella; Marco Gabrielli; Alessandro Bologna; Umberto Albert; Gianfranco Sanson
Journal:  Infect Dis Rep       Date:  2021-07-05

Review 4.  Extracorporeal life support as bridge to recovery in yew poisoning: case reports and literature review.

Authors:  Julia Hermes-Laufer; Martin Meyer; Alain Rudiger; Julian Henze; Kai Enselmann; Hugo Kupferschmidt; Daniel Müller; Aline Herzog; Dominique Bettex; Dagmar I Keller; Bernard Krüger; Judith Engeler
Journal:  ESC Heart Fail       Date:  2020-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.